-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
HIV-1-inhibitor-43
Category | Human immunodeficiency Virus (HIV) |
CAS | 2493426-43-8 |
Description | HIV-1 inhibitor-43 is a potent HIV-1 inhibitor with an EC50 of 21.3 nM, 6.2 nM, < 0.7 nM and < 0.7 nM for Y188L, K103N-Y181C, K103N and Y181C, respectively. HIV-1 inhibitor-43 can reduce HIV-1 RNA and protein p24 expression. |
Product Information
Synonyms | HIV-1 inhibitor-43|CHEMBL4784247|BDBM50556159|HY-150599|CS-0534824|5-chloro-3-(3,5-dimethylphenyl)sulfonyl-N-[(2-hydroxyphenyl)methyl]-1H-indole-2-carboxamide |
Molecular Weight | 468.95 |
Molecular Formula | C24H21ClN2O4S |
Canonical SMILES | CC1=CC(=CC(=C1)S(=O)(=O)C2=C(NC3=C2C=C(C=C3)Cl)C(=O)NCC4=CC=CC=C4O)C |
Purity | ≥98% (HPLC) |
Solubility | 10 mM in DMSO |
Appearance | Solid powder |
Storage | Store at -20°C |
Complexity | 763 |
Exact Mass | 468.0910560 |
In Vitro | HIV-1 inhibitor-43 (compound 12) has anti-HIV-1 activity against HIV-1 reverse transcriptase with IC50s of 83±8 nM, 73±8 nM, 61±6 nM and 76±8 nM for HIV-1 WT, K103N, Y181I and K103N-Y181I, respectively. HIV-1 inhibitor-43 (1, 5 and 25 nM) causes 100% reduction of HIV-1 RNA and protein p24 at 25 nM in C8166 cells infected with a WT strain. |
Target | HIV-1 (Y188L):21.3 nM (EC50) HIV-1 (K103N+Y181C):6.2 nM (EC50) HIV-1 (K103N):<0.7 nM (EC50) HIV-1 (Y181C):<0.7 nM (EC50) |
XLogP3-AA | 5.5 |